vs
IRONWOOD PHARMACEUTICALS INC（IRWD）与COMSCORE, INC.（SCOR）财务数据对比。点击上方公司名可切换其他公司
COMSCORE, INC.的季度营收约是IRONWOOD PHARMACEUTICALS INC的2.0倍（$93.5M vs $47.7M），COMSCORE, INC.净利率更高（3.2% vs -4.8%，领先8.0%），COMSCORE, INC.同比增速更快（-1.5% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $2.9M），过去两年COMSCORE, INC.的营收复合增速更高（3.8% vs -20.2%）
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
Comscore是总部设于美国的全球媒体测量与分析企业，为企业、广告代理商、品牌营销方及媒体出版方提供专业营销数据与分析服务，在全球媒体行业和营销领域拥有广泛影响力。
IRWD vs SCOR — 直观对比
营收规模更大
SCOR
是对方的2.0倍
$47.7M
营收增速更快
SCOR
高出45.8%
-47.3%
净利率更高
SCOR
高出8.0%
-4.8%
自由现金流更多
IRWD
多$71.6M
$2.9M
两年增速更快
SCOR
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.7M | $93.5M |
| 净利润 | $-2.3M | $3.0M |
| 毛利率 | — | 41.0% |
| 营业利润率 | 14.3% | 7.0% |
| 净利率 | -4.8% | 3.2% |
| 营收同比 | -47.3% | -1.5% |
| 净利润同比 | -200.9% | -3.7% |
| 每股收益（稀释后） | $0.01 | $9.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRWDSCOR
| Q4 25 | $47.7M | $93.5M | ||
| Q3 25 | $122.1M | $88.9M | ||
| Q2 25 | $85.2M | $89.4M | ||
| Q1 25 | $41.1M | $85.7M | ||
| Q4 24 | $90.5M | $94.9M | ||
| Q3 24 | $91.6M | $88.5M | ||
| Q2 24 | $94.4M | $85.8M | ||
| Q1 24 | $74.9M | $86.8M |
净利润IRWDSCOR
| Q4 25 | $-2.3M | $3.0M | ||
| Q3 25 | $40.1M | $453.0K | ||
| Q2 25 | $23.6M | $-9.5M | ||
| Q1 25 | $-37.4M | $-4.0M | ||
| Q4 24 | $2.3M | $3.1M | ||
| Q3 24 | $3.6M | $-60.6M | ||
| Q2 24 | $-860.0K | $-1.7M | ||
| Q1 24 | $-4.2M | $-1.1M |
毛利率IRWDSCOR
| Q4 25 | — | 41.0% | ||
| Q3 25 | — | 40.6% | ||
| Q2 25 | — | 40.6% | ||
| Q1 25 | — | 39.6% | ||
| Q4 24 | — | 42.4% | ||
| Q3 24 | — | 41.2% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 42.3% |
营业利润率IRWDSCOR
| Q4 25 | 14.3% | 7.0% | ||
| Q3 25 | 61.8% | 1.9% | ||
| Q2 25 | 53.2% | -1.9% | ||
| Q1 25 | -70.7% | -2.4% | ||
| Q4 24 | 34.8% | 4.1% | ||
| Q3 24 | 28.0% | -67.4% | ||
| Q2 24 | 26.5% | -2.2% | ||
| Q1 24 | 14.7% | -2.2% |
净利率IRWDSCOR
| Q4 25 | -4.8% | 3.2% | ||
| Q3 25 | 32.8% | 0.5% | ||
| Q2 25 | 27.7% | -10.6% | ||
| Q1 25 | -90.9% | -4.7% | ||
| Q4 24 | 2.5% | 3.3% | ||
| Q3 24 | 4.0% | -68.5% | ||
| Q2 24 | -0.9% | -2.0% | ||
| Q1 24 | -5.6% | -1.2% |
每股收益（稀释后）IRWDSCOR
| Q4 25 | $0.01 | $9.50 | ||
| Q3 25 | $0.23 | $-0.86 | ||
| Q2 25 | $0.14 | $-2.73 | ||
| Q1 25 | $-0.23 | $-1.66 | ||
| Q4 24 | $0.03 | $-0.47 | ||
| Q3 24 | $0.02 | $-12.79 | ||
| Q2 24 | $-0.01 | $-1.19 | ||
| Q1 24 | $-0.03 | $-1.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $23.6M |
| 总债务越低越好 | — | $41.5M |
| 股东权益账面价值 | $-261.8M | $111.4M |
| 总资产 | $396.9M | $407.7M |
| 负债/权益比越低杠杆越低 | — | 0.37× |
8季度趋势，按日历期对齐
现金及短期投资IRWDSCOR
| Q4 25 | $215.5M | $23.6M | ||
| Q3 25 | $140.4M | $26.7M | ||
| Q2 25 | $92.9M | $26.0M | ||
| Q1 25 | $108.5M | $31.0M | ||
| Q4 24 | $88.6M | $29.9M | ||
| Q3 24 | $88.2M | $20.0M | ||
| Q2 24 | $105.5M | $14.7M | ||
| Q1 24 | $121.5M | $18.7M |
总债务IRWDSCOR
| Q4 25 | — | $41.5M | ||
| Q3 25 | $199.5M | $41.4M | ||
| Q2 25 | $199.3M | $41.3M | ||
| Q1 25 | $199.2M | $41.3M | ||
| Q4 24 | $199.0M | $41.2M | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
股东权益IRWDSCOR
| Q4 25 | $-261.8M | $111.4M | ||
| Q3 25 | $-264.2M | $-26.3M | ||
| Q2 25 | $-308.2M | $-21.7M | ||
| Q1 25 | $-334.1M | $-13.5M | ||
| Q4 24 | $-301.3M | $-8.3M | ||
| Q3 24 | $-311.3M | $-2.7M | ||
| Q2 24 | $-321.7M | $45.8M | ||
| Q1 24 | $-330.5M | $51.4M |
总资产IRWDSCOR
| Q4 25 | $396.9M | $407.7M | ||
| Q3 25 | $396.1M | $406.9M | ||
| Q2 25 | $342.9M | $415.9M | ||
| Q1 25 | $327.2M | $421.5M | ||
| Q4 24 | $350.9M | $430.2M | ||
| Q3 24 | $389.5M | $412.5M | ||
| Q2 24 | $395.6M | $474.1M | ||
| Q1 24 | $438.8M | $477.7M |
负债/权益比IRWDSCOR
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $74.6M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | $2.9M |
| 自由现金流率自由现金流/营收 | 156.3% | 3.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 1.07× |
| 过去12个月自由现金流最近4个季度 | $127.0M | $21.8M |
8季度趋势，按日历期对齐
经营现金流IRWDSCOR
| Q4 25 | $74.6M | $3.2M | ||
| Q3 25 | $47.6M | $9.5M | ||
| Q2 25 | $-15.1M | $932.0K | ||
| Q1 25 | $20.0M | $9.1M | ||
| Q4 24 | $15.2M | $-10.0M | ||
| Q3 24 | $9.9M | $12.5M | ||
| Q2 24 | $33.5M | $8.7M | ||
| Q1 24 | $45.0M | $6.9M |
自由现金流IRWDSCOR
| Q4 25 | $74.6M | $2.9M | ||
| Q3 25 | $47.6M | $9.4M | ||
| Q2 25 | $-15.1M | $787.0K | ||
| Q1 25 | $19.9M | $8.7M | ||
| Q4 24 | — | $-10.3M | ||
| Q3 24 | $9.9M | $12.4M | ||
| Q2 24 | $33.4M | $8.5M | ||
| Q1 24 | $44.9M | $6.6M |
自由现金流率IRWDSCOR
| Q4 25 | 156.3% | 3.1% | ||
| Q3 25 | 39.0% | 10.5% | ||
| Q2 25 | -17.7% | 0.9% | ||
| Q1 25 | 48.4% | 10.1% | ||
| Q4 24 | — | -10.8% | ||
| Q3 24 | 10.8% | 14.0% | ||
| Q2 24 | 35.4% | 10.0% | ||
| Q1 24 | 60.0% | 7.6% |
资本支出强度IRWDSCOR
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.1% | 0.3% |
现金转化率IRWDSCOR
| Q4 25 | — | 1.07× | ||
| Q3 25 | 1.19× | 20.96× | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | -3.19× | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRWD
暂无分部数据
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
